共 71 条
Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy
被引:885
作者:
Morgan, Richard A.
[1
]
Chinnasamy, Nachimuthu
[1
]
Abate-Daga, Daniel
[1
]
Gros, Alena
[1
]
Robbins, Paul F.
[1
]
Zheng, Zhili
[1
]
Dudley, Mark E.
[1
]
Feldman, Steven A.
[1
]
Yang, James C.
[1
]
Sherry, Richard M.
[1
]
Phan, Giao Q.
[1
]
Hughes, Marybeth S.
[1
]
Kammula, Udai S.
[1
]
Miller, Akemi D.
[1
]
Hessman, Crystal J.
[1
]
Stewart, Ashley A.
[1
]
Restifo, Nicholas P.
[1
]
Quezado, Martha M.
[2
]
Alimchandani, Meghna
[2
]
Rosenberg, Avi Z.
[2
]
Nath, Avindra
[3
]
Wang, Tongguang
[3
]
Bielekova, Bibiana
[3
]
Wuest, Simone C.
[3
]
Akula, Nirmala
[4
]
McMahon, Francis J.
[4
]
Wilde, Susanne
[5
]
Mosetter, Barbara
[5
]
Schendel, Dolores J.
[5
,6
]
Laurencot, Carolyn M.
[1
]
Rosenberg, Steven A.
[1
]
机构:
[1] NCI, Surg Branch, Bethesda, MD 20892 USA
[2] NCI, Pathol Lab, Bethesda, MD 20892 USA
[3] NINDS, Neuroimmunol Branch, Bethesda, MD 20892 USA
[4] NIMH, Human Genet Branch, Bethesda, MD 20892 USA
[5] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Mol Immunol, Munich, Germany
[6] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Clin Cooperat Grp Immune Monitoring, Munich, Germany
关键词:
cancer-testes antigen;
immunotherapy;
TCR;
gene therapy;
INFLAMMATORY DEMYELINATING POLYNEUROPATHY;
MAGE-A FAMILY;
METASTATIC MELANOMA;
CANCER/TESTIS ANTIGENS;
PROSTATE-CANCER;
ADVERSE EVENT;
HIGH AVIDITY;
CELLS;
EXPRESSION;
TARGETS;
D O I:
10.1097/CJI.0b013e3182829903
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
Nine cancer patients were treated with adoptive cell therapy using autologous anti-MAGE-A3 T-cell receptors (TCR)engineered T cells. Five patients experienced clinical regression of their cancers including 2 on-going responders. Beginning 1-2 days postinfusion, 3 patients (#'s 5, 7, and 8) experienced mental status changes, and 2 patients (5 and 8) lapsed into comas and subsequently died. Magnetic resonance imagining analysis of patients 5 and 8 demonstrated periventricular leukomalacia, and examination of their brains at autopsy revealed necrotizing leukoence-phalopathy with extensive white matter defects associated with infiltration of CD3(+) /CD8(+) T cells. Patient 7, developed Parkinson- like symptoms, which resolved over 4 weeks and fully recovered. Immunohistochemical staining of patient and normal brain samples demonstrated rare positively staining neurons with an antibody that recognizes multiple MAGE-A family members. The TCR used in this study recognized epitopes in MAGE-A3/A9/A12. Molecular assays of human brain samples using real-time quantitative-polymerase chain reaction, Nanostring quantitation, and deep-sequencing indicated that MAGE-A12 was expressed in human brain (and possibly MAGE-A1, MAGE-A8, and MAGEA9). This previously unrecognized expression of MAGE-A12 in human brain was possibly the initiating event of a TCR-mediated inflammatory response that resulted in neuronal cell destruction and raises caution for clinical applications targeting MAGE-A family members with highly active immunotherapies.
引用
收藏
页码:133 / 151
页数:19
相关论文